|
1
|
Hema KN, Smitha T, Sheethal HS and
Mirnalini SA: Epigenetics in oral squamous cell carcinoma. J Oral
Maxillofac Pathol. 21:252–259. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mourad M, Jetmore T, Jategaonkar AA,
Moubayed S, Moshier E and Urken ML: Epidemiological trends of head
and neck cancer in the united states: A SEER population study. J
Oral Maxillofac Surg. 75:2562–2572. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nakashima C, Yamamoto K, Fujiwara-Tani R,
Luo Y, Matsushima S, Fujii K, Ohmori H, Sasahira T, Sasaki T,
Kitadai Y, et al: Expression of cytosolic malic enzyme (ME1) is
associated with disease progression in human oral squamous cell
carcinoma. Cancer Sci. 109:2036–2045. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Alessandro F and Irene B: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Marín-Béjar O, Mas AM, González J,
Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E,
Guo S, et al: The human lncRNA LINC-PINT inhibits tumor cell
invasion through a highly conserved sequence element. Genome Biol.
18(202)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang S, Tian L, Ma P, Sun Q, Zhang K,
Wang G, Liu H and Xu B: Potential role of differentially expressed
lncRNAs in the pathogenesis of oral squamous cell carcinoma. Arch
Oral Biol. 60:1581–1587. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chang SM and Hu WW: Long non-coding RNA
MALAT1 promotes oral squamous cell carcinoma development via
microRNA-125b/STAT3 axis. J Cell Physiol. 233:3384–3396.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Abdulaziz MA, Amin AK, Elrouby DH and
Shaker OG: Lymphangiogenesis in oral squamous cell carcinoma:
Correlation with VEGF-C expression and lymph node metastasis. Int J
Dent. 2017(7285656)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiao H, Zhang F, Zou Y, Li J, Liu Y and
Huang W: The function and mechanism of long non-coding RNA-ATB in
cancers. Front Physiol. 9(321)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fan S, Fan C, Liu N, Huang K, Fang X and
Wang K: Downregulation of the long non-coding RNA ZFAS1 is
associated with cell proliferation, migration and invasion in
breast cancer. Mol Med Rep. 17:6405–6412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang L, Wang H, Xu M, Chen F, Li W, Hu H,
Yuan Q, Su Y, Liu X, Wuri J and Yan T: Long noncoding RNA HAS2-AS1
promotes tumor progression in glioblastoma via functioning as a
competing endogenous RNA. J Cell Biochem. 121:661–671.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang C, Zheng J, Xue Y, Yu H, Liu X, Ma J,
Liu L, Wang P, Li Z, Cai H and Liu Y: The effect of
MCM3AP-AS1/miR-211/KLF5/AGGF1 axis regulating glioblastoma
angiogenesis. Front Mol Neurosci. 10(437)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18(28)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Behbahani GD, Ghahhari NM, Javidi MA,
Molan AF, Feizi N and Babashah S: MicroRNA-mediated
post-transcriptional regulation of epithelial to mesenchymal
transition in cancer. Pathol Oncol Res. 23:1–12. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao
H and Teschendorff AE: dbDEMC 2.0: Updated database of
differentially expressed miRNAs in human cancers. Nucleic Acids
Res. 45 (D1):D812–D818. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Qiao J, Lee S, Paul P, Theiss L, Tiao J,
Lan Q, Kong A and Dai HC: miR-335 and miR-363 regulation of
neuroblastoma tumorigenesis and metastasis. Surgery. 154:226–233.
2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan
M, Wu X and Chen W: Dysregulated miR-363 affects head and neck
cancer invasion and metastasis by targeting podoplanin. Int J
Biochem Cell Biol. 45:513–520. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Song B, Yan J, Liu C, Zhou H and Zheng Y:
Tumor suppressor role of miR-363-3p in gastric cancer. Med Sci
Monit. 21:4074–4080. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang J, Fan J, Zhou C and Qi Y:
miR-363-5p as potential prognostic marker for hepatocellular
carcinoma indicated by weighted co-expression network analysis of
miRNAs and mRNA. BMC Gastroenterol. 17(81)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen G, Sun W, Hua X, Zeng W and Yang L:
Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma
carcinogenesis by modulating miR-363-5p/S100A1 pathway. Gene.
645:76–84. 2018.PubMed/NCBI View Article : Google Scholar
|
